Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa L Ioannides-Demos

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cardiovascular Drugs and Therapy|July 6, 2010
Smoking cessation-recent advancesJohn J McNeil, Loretta Piccenna, Lisa L Ioannides-Demos
Journal of Obesity|January 4, 2011
Pharmacotherapies for obesity: past, current, and future therapiesLisa L Ioannides-Demos, Loretta Piccenna, John J McNeil
Drugs|June 28, 2005
Pharmacotherapy for obesityLisa L Ioannides-Demos, Joseph Proietto, John J McNeil
Pharmacoeconomics|July 27, 2002
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomesLisa L Ioannides-Demos, Joseph E Ibrahim, John J McNeil
Drug Safety|March 30, 2006
Safety of drug therapies used for weight loss and treatment of obesityLisa L Ioannides-Demos, Joseph Proietto, Andrew M Tonkin, et al.
Clinical Drug Investigation|June 10, 2010
Cost of myocardial infarction to the Australian community: a prospective, multicentre surveyLisa L Ioannides-Demos, Kelly Makarounas-Kirchmann, Emma Ashton, et al.
The Medical Journal of Australia|September 7, 2004
Use of complementary and alternative medicines by patients with chronic obstructive pulmonary diseaseJohnson George, Lisa L Ioannides-Demos, Nick M Santamaria, et al.
The Medical Journal of Australia|June 18, 2002
Ceftriaxone and cefotaxime use in Victorian hospitalsMarion B Robertson, Tony M Korman, Jonathan G A Dartnell, et al.
Environmental Health Perspectives|March 4, 2003
Fenitrothion: toxicokinetics and toxicologic evaluation in human volunteersJean Meaklim, Jinming Yang, Olaf H Drummer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cardiovascular Drugs and Therapy|July 6, 2010
Smoking cessation-recent advancesJohn J McNeil, Loretta Piccenna, Lisa L Ioannides-Demos
Journal of Obesity|January 4, 2011
Pharmacotherapies for obesity: past, current, and future therapiesLisa L Ioannides-Demos, Loretta Piccenna, John J McNeil
Drugs|June 28, 2005
Pharmacotherapy for obesityLisa L Ioannides-Demos, Joseph Proietto, John J McNeil
Pharmacoeconomics|July 27, 2002
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomesLisa L Ioannides-Demos, Joseph E Ibrahim, John J McNeil
Drug Safety|March 30, 2006
Safety of drug therapies used for weight loss and treatment of obesityLisa L Ioannides-Demos, Joseph Proietto, Andrew M Tonkin, et al.
Clinical Drug Investigation|June 10, 2010
Cost of myocardial infarction to the Australian community: a prospective, multicentre surveyLisa L Ioannides-Demos, Kelly Makarounas-Kirchmann, Emma Ashton, et al.
The Medical Journal of Australia|September 7, 2004
Use of complementary and alternative medicines by patients with chronic obstructive pulmonary diseaseJohnson George, Lisa L Ioannides-Demos, Nick M Santamaria, et al.
The Medical Journal of Australia|June 18, 2002
Ceftriaxone and cefotaxime use in Victorian hospitalsMarion B Robertson, Tony M Korman, Jonathan G A Dartnell, et al.
Environmental Health Perspectives|March 4, 2003
Fenitrothion: toxicokinetics and toxicologic evaluation in human volunteersJean Meaklim, Jinming Yang, Olaf H Drummer, et al.
Pageof 1